Trans Genic Receives Japanese Patent on Cancer Diagnosis Method Using Urine Samples.Tokyo, Japan, July 4, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Trans Genic genic /gen·ic/ (jen´ik) pertaining to or caused by the genes. gen·ic adj. Of, relating to, produced by, or being genes or a gene. genic pertaining to or caused by the genes. has announced that it has obtained a Japanese patent (JP3816512) on a high-sensitive immunological assay system for cancer diagnosis from the japan Patent Office. The patented method, which uses anti-diacetylspermine antibodies and urine samples, can diagnose early stage cancer in a simplified and noninvasive manner. Going forward, Trans Genic will strive to develop an in vitro in vitro /in vi·tro/ (in ve´tro) [L.] within a glass; observable in a test tube; in an artificial environment. in vi·tro adj. In an artificial environment outside a living organism. reagent reagent /re·a·gent/ (re-a´jent) a substance used to produce a chemical reaction so as to detect, measure, produce, etc., other substances. re·a·gent n. based on this patent in collaboration with several companies. In addition, the company has filed a application for this patent in the US. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion